for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

AmerisourceBergen Corp.

ABC.N

現在値

119.55USD

変化

-3.41(-2.77%)

出来高

202,481

本日のレンジ

119.54

 - 

122.56

52週レンジ

92.32

 - 

128.76

∙ 約20分前の相場を表示しています。

適時開示

Drug Distributors Announce Proposed Opioid Settlement Will Proceed To Next Phase

Sept 4 (Reuters) - Mckesson Corp: :DISTRIBUTORS ANNOUNCE PROPOSED OPIOID SETTLEMENT WILL PROCEED TO NEXT PHASE.MCKESSON- UNDER PREVIOUSLY SAID PROPOSED SETTLEMENT DEAL, PROCESS DESIGNED TO RESOLVE OPIOID CLAIMS OF STATE & LOCAL GOVERNMENTAL ENTITIES ENOUGH STATES AGREED TO SETTLE TO PROCEED TO NEXT PHASE.ALL 5 TERRITORIES AND WASHINGTON DC HAD AFFIRMATIVELY SIGNED ON TO AGREEMENT..THIS NEXT PHASE IS NOTICE TO SUBDIVISIONS, AND SUBDIVISION SIGN-ON PERIOD.MCKESSON- IF CONDITIONS ARE SATISFIED, SETTLEMENT WOULD BECOME EFFECTIVE 60 DAYS AFTER DISTRIBUTORS DETERMINE THAT THERE IS SUFFICIENT PARTICIPATION TO PROCEED.FINAL PAYMENT AMOUNT WILL DEPEND ON SEVERAL FACTORS, INCLUDING FINAL PARTICIPATION RATE OF STATES AND POLITICAL SUBDIVISIONS.COMPANIES WILL MAKE THEIR FIRST ANNUAL SETTLEMENT PAYMENT INTO ESCROW ON OR BEFORE SEPTEMBER 30, 2021.PAYMENT WILL BE DISBURSED FOLLOWING EFFECTIVE DATE OR RETURNED TO DISTRIBUTORS IF SETTLEMENT DOES NOT BECOME EFFECTIVE.

Amerisourcebergen Reports Fiscal 2021 Third Quarter Results

Aug 4 (Reuters) - Amerisourcebergen Corp <ABC.N>::AMERISOURCEBERGEN REPORTS FISCAL 2021 THIRD QUARTER RESULTS.Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $2.16 EXCLUDING ITEMS.Q3 GAAP EARNINGS PER SHARE $1.40.Q3 EARNINGS PER SHARE ESTIMATE $2.05 -- REFINITIV IBES DATA.ADJUSTED DILUTED EPS GUIDANCE RANGE RAISED TO $9.15 TO $9.30 FOR FISCAL 2021.REVENUES OF $53.4 BILLION FOR Q3, A 17.7 PERCENT INCREASE YEAR-OVER-YEAR.Q3 REVENUE VIEW $52.35 BILLION -- REFINITIV IBES DATA.ADJUSTED FREE CASH FLOW FOR FY 2021 TO BE APPROXIMATELY $1.7 BILLION, UP FROM APPROXIMATELY $1.5 BILLION.

AmerisourceBergen, Cardinal Health & McKesson Announce Proposed Opioid Settlement Agreement

July 21 (Reuters) - Amerisourcebergen Corp <ABC.N>::AMERISOURCEBERGEN - COS NEGOTIATED PROPOSED AGREEMENT TO SETTLE A SUBSTANTIAL MAJORITY OF OPIOID LAWSUITS FILED BY STATE & LOCAL GOVERNMENTAL ENTITIES.AMERISOURCEBERGEN - BELIEVE PROPOSED AGREEMENT, SETTLEMENT PROCESS, ARE IMPORTANT STEPS TOWARD ACHIEVING RESOLUTION OF GOVERNMENTAL OPIOID CLAIMS.AMERISOURCEBERGEN CORP - AS PART OF SETTLEMENT, WOULD BE RESPONSIBLE FOR CONTRIBUTIONS OF UP TO $6.4 BILLION, PAYABLE OVER 18 YEARS.AMERISOURCEBERGEN CORP - COMPANIES WILL MAKE THEIR FIRST ANNUAL SETTLEMENT PAYMENT INTO ESCROW ON OR BEFORE SEPTEMBER 30, 2021.AMERISOURCEBERGEN CORP - AS PART OF SETTLEMENT, CARDINAL HEALTH WOULD BE RESPONSIBLE FOR CONTRIBUTIONS OF UP TO $6.4 BILLION, PAYABLE OVER 18 YEARS.AMERISOURCEBERGEN CORP - AS PART OF SETTLEMENT, MCKESSON WOULD BE RESPONSIBLE FOR CONTRIBUTIONS OF UP TO $7.9 BILLION, PAYABLE OVER 18 YEARS.AMERISOURCEBERGEN - IF SETTLEMENT CANNOT BE FINALIZED & PLAINTIFFS PURSUE CLAIMS, COS WILL CONTINUE TO ASSERT LEGAL DEFENSES IN PENDING LITIGATION.

Amerisourcebergen Reports Q2 GAAP EPS $2.10

May 5 (Reuters) - Amerisourcebergen Corp <ABC.N>::AMERISOURCEBERGEN REPORTS FISCAL 2021 SECOND QUARTER RESULTS.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $2.53 EXCLUDING ITEMS.Q2 GAAP EARNINGS PER SHARE $2.10.REVENUES OF $49.2 BILLION FOR Q2, A 3.7 PERCENT INCREASE YEAR-OVER-YEAR.ADJUSTED DILUTED EPS GUIDANCE RANGE RAISED TO $8.45 TO $8.60 FOR FISCAL 2021.Q2 EARNINGS PER SHARE VIEW $2.48, REVENUE VIEW $49.97 BILLION -- REFINITIV IBES DATA.

AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 And $1.0 Billion 2.700% Senior Notes Due 2031

March 25 (Reuters) - Amerisourcebergen Corp <ABC.N>::AMERISOURCEBERGEN PRICES $1.525 BILLION 0.737% SENIOR NOTES DUE 2023 AND $1.0 BILLION 2.700% SENIOR NOTES DUE 2031.

AmerisourceBergen Reports Fiscal 2021 First Quarter Results

Feb 4 (Reuters) - Amerisourcebergen Corp <ABC.N>::AMERISOURCEBERGEN REPORTS FISCAL 2021 FIRST QUARTER RESULTS.Q1 ADJUSTED NON-GAAP EARNINGS PER SHARE $2.18 EXCLUDING ITEMS.Q1 GAAP EARNINGS PER SHARE $1.81.Q1 EARNINGS PER SHARE ESTIMATE $1.94 -- REFINITIV IBES DATA.UPDATING ITS OUTLOOK FOR FISCAL YEAR 2021.REVENUES OF $52.5 BILLION FOR Q1, A 9.7 PERCENT INCREASE YEAR-OVER-YEAR.AMERISOURCEBERGEN - ADJUSTED DILUTED EPS GUIDANCE HAS BEEN RAISED FROM PREVIOUS EXPECTATION OF $8.25 TO $8.50 TO A RANGE OF $8.40 TO $8.60 FOR FY 2021.SEES FY 2021 REVENUE GROWTH IN HIGH-SINGLE DIGIT PERCENT RANGE, UP FROM MID-SINGLE DIGIT PERCENT RANGE.ALL OTHER PREVIOUSLY COMMUNICATED ASPECTS OF CO'S FISCAL YEAR 2021 FINANCIAL GUIDANCE AND ASSUMPTIONS REMAIN SAME.Q1 REVENUE VIEW $50.49 BILLION -- REFINITIV IBES DATA.FY2021 EARNINGS PER SHARE VIEW $8.40 -- REFINITIV IBES DATA.

Amerisourcebergen Sees FY 2021 Adjusted Earnings Per Share $8.25 To $8.50

Jan 6 (Reuters) - Amerisourcebergen Corp <ABC.N>::AMERISOURCEBERGEN ANNOUNCES UPDATED FISCAL YEAR 2021 FINANCIAL OUTLOOK.SEES FY 2021 ADJUSTED EARNINGS PER SHARE $8.25 TO $8.50.OTHER PREVIOUSLY COMMUNICATED ASPECTS OF FISCAL YEAR 2021 FINANCIAL GUIDANCE AND ASSUMPTIONS REMAIN SAME.FY2021 EARNINGS PER SHARE VIEW $8.41 -- REFINITIV IBES DATA.

AmerisourceBergen And Walgreens Boots Alliance Announce Strategic Transaction

Jan 6 (Reuters) - Amerisourcebergen Corp <ABC.N>::AMERISOURCEBERGEN AND WALGREENS BOOTS ALLIANCE ANNOUNCE STRATEGIC TRANSACTION.WALGREENS BOOTS ALLIANCE INC - AMERISOURCEBERGEN TO ACQUIRE ALLIANCE HEALTHCARE BUSINESSES FROM WALGREENS BOOTS ALLIANCE FOR $6.5 BILLION.WALGREENS BOOTS ALLIANCE INC - DEAL FOR APPROXIMATELY $6.5 BILLION, COMPRISED OF $6.275 BILLION IN CASH AND 2 MILLION SHARES OF AMERISOURCEBERGEN COMMON STOCK.WALGREENS BOOTS ALLIANCE INC - AMERISOURCEBERGEN EXPECTS TO FUND CASH PURCHASE PRICE THROUGH A COMBINATION OF CASH ON HAND AND NEW DEBT FINANCING.WALGREENS BOOTS ALLIANCE INC - WALGREENS BOOTS ALLIANCE'S OPERATIONS IN CHINA, ITALY AND GERMANY ARE NOT PART OF TRANSACTION.WALGREENS BOOTS ALLIANCE INC - ACQUISITION IS EXPECTED TO DELIVER HIGH-TEENS PERCENTAGE ACCRETION TO AMERISOURCEBERGEN'S ADJUSTED EPS IN FIRST YEAR.WALGREENS BOOTS ALLIANCE - AMERISOURCEBERGEN EXPECTS SYNERGIES FROM ACQUISITION TO RAMP TO AN ANNUAL RUN-RATE OF $75 MILLION IN FOURTH YEAR.WALGREENS BOOTS ALLIANCE INC - ACQUISITION IS EXPECTED TO HAVE NO IMPACT ON AMERISOURCEBERGEN'S DIVIDEND POLICY..WALGREENS BOOTS ALLIANCE INC - TRANSACTION WILL BE SLIGHTLY DILUTIVE IN CURRENT FINANCIAL YEAR FOR CO, BUT WILL BE ACCRETIVE LONGER-TERM.WALGREENS BOOTS ALLIANCE INC - U.S. DISTRIBUTION AGREEMENT BETWEEN TWO COMPANIES WILL BE EXTENDED BY THREE YEARS UNTIL 2029.WALGREENS BOOTS ALLIANCE INC - ALLIANCE HEALTHCARE UK WILL REMAIN DISTRIBUTION PARTNER OF BOOTS UNTIL 2031..

Lilly's Neutralizing Antibody Receives FDA Emergency Use Nod For Treatment Of Recently Diagnosed COVID-19

Nov 9 (Reuters) - Eli Lilly and Co <LLY.N>::LILLY'S NEUTRALIZING ANTIBODY BAMLANIVIMAB (LY-COV555) RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR THE TREATMENT OF RECENTLY DIAGNOSED COVID-19.ELI LILLY AND CO - U.S. GOVERNMENT WILL ALLOCATE 300,000 DOSES OF BAMLANIVIMAB TO HIGH-RISK PATIENTS, WITH NO OUT-OF-POCKET COSTS FOR MEDICATION.ELI LILLY AND CO - FDA GRANTED EUA FOR CO'S INVESTIGATIONAL NEUTRALIZING ANTIBODY BAMLANIVIMAB (LY-COV555) 700 MG.ELI LILLY AND CO - EUA INCLUDES A WARNING FOR HYPERSENSITIVITY INCLUDING ANAPHYLAXIS AND INFUSION-RELATED REACTIONS.ELI LILLY - WILL BEGIN SHIPPING BAMLANIVIMAB IMMEDIATELY TO AMERISOURCEBERGEN, WHICH WILL DISTRIBUTE IT AS DIRECTED BY U.S. GOVERNMENT'S ALLOCATION PROGRAM.

Amerisourcebergen Reports Q4 Adjusted Earnings Per Share $1.89

Nov 5 (Reuters) - Amerisourcebergen Corp <ABC.N>::AMERISOURCEBERGEN REPORTS FISCAL 2020 FOURTH QUARTER AND YEAR END RESULTS.Q4 ADJUSTED EARNINGS PER SHARE $1.89.Q4 GAAP LOSS PER SHARE $23.74.Q4 EARNINGS PER SHARE ESTIMATE $1.85 -- REFINITIV IBES DATA.REVENUE OF $49.2 BILLION FOR Q4, A 7.9 PERCENT INCREASE YEAR-OVER-YEAR.RECORDED A $6.6 BILLION ($5.5 BILLION AFTER TAX) CHARGE, WHICH IS EXCLUDED FROM ITS ADJUSTED (NON-GAAP) QTRLY RESULTS.AMERISOURCEBERGEN - IS IN ADVANCED DISCUSSIONS, WHICH ARE ONGOING, TO REACH A GLOBAL SETTLEMENT TO BE PAID OVER AN 18-YEAR PERIOD TO RESOLVE CASES.EXPECTS 2021 REVENUE GROWTH IN MID-SINGLE DIGIT PERCENT RANGE, ON AN ADJUSTED BASIS.SEES 2021 ADJUSTED DILUTED EARNINGS PER SHARE TO BE IN RANGE OF $8.20 TO $8.45..SEES 2021 ADJUSTED FREE CASH FLOW TO BE ABOUT $1.5 BILLION.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up